Posts Tagged ‘commission’
Baxter Receives European Commission Approval For CELVAPAN H1N1 Pandemic Influenza Vaccine
Baxter International Inc. (NYSE: BAX) confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter’s Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union. Baxter continues to deliver vaccine to national public health authorities that have agreements with the company.
Joint Commission Offers Seasonal Flu Immunization Strategies
Seasonal influenza in health care workers is a personal health threat, but also poses a significant risk to the patients in their care. In an effort to help health care organizations improve the rate of health care worker influenza vaccinations, The Joint Commission is releasing a monograph “Providing a Safer Environment for Health Care Personnel and Patients Through Influenza Vaccination: Strategies from Research and Practice.
CMS Recognizes The Joint Commission For Continued Hospice Deeming Authority – Deemed Status Option Renewed
The Department of Health and Human Services’ Centers for Medicare & Medicaid Services (CMS) has renewed The Joint Commission’s deeming authority for hospice organizations for the maximum six-year term allowed. The six-year designation means that hospice organizations accredited by The Joint Commission will be “deemed” as meeting Medicare and Medicaid certification requirements and are eligible for Medicare reimbursement.
Rx Drug Compare
Translator
By N2H